Future Fields uses an insect-based recombinant protein manufacturing platform to produce high quality products needed in vaccines, growth media, and therapeutics, but with a 700x to 3000x smaller GHG footprint than existing bioreactor technology.

We have the potential to be a major circular economy player, using waste products to create high quality GMP outputs. We are strong proponents of the triple bottom line, with our ethos being to help people and the planet, while still generating profit. We are aligned with the UN Climate Action Plan, and are proud to be addressing 10 of the 17 UN Sustainable Development Goals.

Zero-waste biomanufacturing is the future, join us to make this future a reality.